Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data

Total article views   HTML views PDF downloads Totals
13,372 Dovepress* 10,664+ 1,584 12,248
PubMed Central* 2,708 390 3,098
Totals 13,372 1,974 15,346
*Since 20 June 2012
+Since July 2016

View citations on PubMed Central and Google Scholar